Next, distinguished transcripts in phase I (ADH5, AKRB10, AKR7A2, ALDH1A1, EPHX1, EPHX2, MAOA, and PTGS1) have decreased expression in all stages of CRC development. Here, EPHX2 is linked to colorectal carcinoma.